No evidence for association of MTHFR 677C>T and 1298A>C variants with placental DNA methylation.

ABSTRACT: Background:5,10-Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in one-carbon metabolism that ensures the availability of methyl groups for methylation reactions. Two single-nucleotide polymorphisms (SNPs) in the MTHFR gene, 677C>T and 1298A>C, result in a thermolabile enzyme with reduced function. These variants, in both the maternal and/or fetal genes, have been associated with pregnancy complications including miscarriage, neural tube defects (NTDs), and preeclampsia (PE), perhaps due to altered capacity for DNA methylation (DNAm). In this study, we assessed the association between MTHFR 677TT and 1298CC genotypes and risk of NTDs, PE, or normotensive intrauterine growth restriction (nIUGR). Additionally, we assessed whether these high-risk genotypes are associated with altered DNAm in the placenta. Results:In 303 placentas screened for this study, we observed no significant association between the occurrence of NTDs (N?=?55), PE (early-onset: N?=?28, late-onset: N?=?20), or nIUGR (N?=?21) and placental (fetal) MTHFR 677TT or 1298CC genotypes compared to healthy pregnancies (N?=?179), though a trend of increased 677TT genotype in PE/IUGR together was observed (OR 2.53, p?=?0.048). DNAm was profiled in 10 high-risk 677 (677TT + 1298AA), 10 high-risk 1298 (677CC + 1298CC), and 10 reference (677CC + 1298AA) genotype placentas. Linear modeling identified no significantly differentially methylated sites between high-risk 677 or 1298 and reference placentas at a false discovery rate

SUBMITTER: Del Gobbo GF 

PROVIDER: S-EPMC5851070 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature